{"ticker": {"uuid": "2928c04b-b5d5-45a4-b88a-ca7de9e285bc", "symbol": "PILA", "name": "Pila Pharma AB (publ)", "exchange": "STO", "country": "SE", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "REPORT FROM PILA PHARMA AB\u2019S ANNUAL GENERAL MEETING 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPd013bk40alJVRFpCTFdIakdKT2lpdXBIdWo4OEp6Q045TXlUNlIwYVFNYVcwa2pKbEc1a2Y4MktheERCcTNmYm5fN2ZkNGMyc195Rnh5bDBzRGlSRk5vbXotdlpJdnNGTjhfanhmbU5oMHdOZVZ0X1dWajJ5cXVjZWdLN0lfSUtpc0J2eEZjUjhLNVhmWWVLRlZSLXBib2hVRGZ2d3BMUFhaX1RjdkJTSVVEdlc0UkIwZ0JFS0NYTQ?oc=5", "source_name": "TradingView", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pila Pharma stands out in next-generation obesity pipeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQdm1vMzdhNjlMejdnRHFYWlAtV0QxYXpoR3A4Z1hMYmtyS3F3OXR5LUNnYl9IUmsySUZkSVlmSHVPZHgxLU5OdERncnlyWmZrUEEtbENDXzk2Um9pR2lvMUlUVmZPSTRrZUhaVHV2Sk1pb25pY1BSTzhoVENUSTFnUXpMR3lqdndjQ29lS2x3a3dsM2s0blhqWkxSejQ?oc=5", "source_name": "Biostock", "published_at": "2025-11-05T08:00:00+00:00", "published_display": "05 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pila Pharma share issue for obesity drug research is massively oversubscribed", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxPWHM0WU96YzBHcFFzYW9FS3VJOEZWX091bUZ4akRxX1hXOGRQUzJRTWFQdTlYMjA2cS10QnVMazVkMm5fOS03a2FFX0t2TzkxYzNMSE8zczJkRTNDZEFaYVIxSE9PRHk2Q3p2c3RzN0laT1JhcF9WYjdVU2k3aW1FU1lDN2VZXzhEdUt2clBBdU0tckdhbHM4SGoyNUNDc0dqZ1ZqazJKQXBkR0pDTDcxZGdQbWswRExVMUVjdUNHVkRvckgwOGRTUm5vTE5ZZ0p1NDBlTGFR?oc=5", "source_name": "The Armchair Trader", "published_at": "2025-11-03T08:00:00+00:00", "published_display": "03 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pila Pharma broadens XEN-D0501 with new indication", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxOcjdMVDUwNG1wSXp3SmdjNGh5OW4wOGxXeV9XNUZHZWhBSzgtRTJ3cVFybUxUNGNHYm9tbXNtOGtBM0dSTXVYRU9QMmlOQ1VwbndDWDFzTEpZWUZCZnBmM3pBcUZqUUFPdHdJb1Y0MlRyc0otR1YzZTlXZGFna1lBR1BkTm1NRGJPY243cFEyc1g0TVU?oc=5", "source_name": "Biostock", "published_at": "2022-09-30T09:40:27+00:00", "published_display": "30 Sep 2022 09:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CEO of Pila Pharma increases share holding to over a third", "summary": "", "url": "https://news.google.com/rss/articles/CBMib0FVX3lxTE8xOEl3aU5SRDVXWFFfM0V5em94bjJQaEwxMmlXcXFXc0dVYkdUUUJscHJZQlQ2S21wOFJQX181TWl0QVZrUDdFc2dCQl9pdmZvWnNmdDhZZjZiXzF2YTZNQVhKeTVFNVlmaEZDNm5Vaw?oc=5", "source_name": "medwatch.com", "published_at": "2021-11-17T08:00:00+00:00", "published_display": "17 Nov 2021 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "REPORT FROM PILA PHARMA AB\u2019S ANNUAL GENERAL MEETING 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPd013bk40alJVRFpCTFdIakdKT2lpdXBIdWo4OEp6Q045TXlUNlIwYVFNYVcwa2pKbEc1a2Y4MktheERCcTNmYm5fN2ZkNGMyc195Rnh5bDBzRGlSRk5vbXotdlpJdnNGTjhfanhmbU5oMHdOZVZ0X1dWajJ5cXVjZWdLN0lfSUtpc0J2eEZjUjhLNVhmWWVLRlZSLXBib2hVRGZ2d3BMUFhaX1RjdkJTSVVEdlc0UkIwZ0JFS0NYTQ?oc=5", "source_name": "TradingView", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pila Pharma stands out in next-generation obesity pipeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQdm1vMzdhNjlMejdnRHFYWlAtV0QxYXpoR3A4Z1hMYmtyS3F3OXR5LUNnYl9IUmsySUZkSVlmSHVPZHgxLU5OdERncnlyWmZrUEEtbENDXzk2Um9pR2lvMUlUVmZPSTRrZUhaVHV2Sk1pb25pY1BSTzhoVENUSTFnUXpMR3lqdndjQ29lS2x3a3dsM2s0blhqWkxSejQ?oc=5", "source_name": "Biostock", "published_at": "2025-11-05T08:00:00+00:00", "published_display": "05 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pila Pharma share issue for obesity drug research is massively oversubscribed", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxPWHM0WU96YzBHcFFzYW9FS3VJOEZWX091bUZ4akRxX1hXOGRQUzJRTWFQdTlYMjA2cS10QnVMazVkMm5fOS03a2FFX0t2TzkxYzNMSE8zczJkRTNDZEFaYVIxSE9PRHk2Q3p2c3RzN0laT1JhcF9WYjdVU2k3aW1FU1lDN2VZXzhEdUt2clBBdU0tckdhbHM4SGoyNUNDc0dqZ1ZqazJKQXBkR0pDTDcxZGdQbWswRExVMUVjdUNHVkRvckgwOGRTUm5vTE5ZZ0p1NDBlTGFR?oc=5", "source_name": "The Armchair Trader", "published_at": "2025-11-03T08:00:00+00:00", "published_display": "03 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Pila Pharma broadens XEN-D0501 with new indication", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxOcjdMVDUwNG1wSXp3SmdjNGh5OW4wOGxXeV9XNUZHZWhBSzgtRTJ3cVFybUxUNGNHYm9tbXNtOGtBM0dSTXVYRU9QMmlOQ1VwbndDWDFzTEpZWUZCZnBmM3pBcUZqUUFPdHdJb1Y0MlRyc0otR1YzZTlXZGFna1lBR1BkTm1NRGJPY243cFEyc1g0TVU?oc=5", "source_name": "Biostock", "published_at": "2022-09-30T09:40:27+00:00", "published_display": "30 Sep 2022 09:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CEO of Pila Pharma increases share holding to over a third", "summary": "", "url": "https://news.google.com/rss/articles/CBMib0FVX3lxTE8xOEl3aU5SRDVXWFFfM0V5em94bjJQaEwxMmlXcXFXc0dVYkdUUUJscHJZQlQ2S21wOFJQX181TWl0QVZrUDdFc2dCQl9pdmZvWnNmdDhZZjZiXzF2YTZNQVhKeTVFNVlmaEZDNm5Vaw?oc=5", "source_name": "medwatch.com", "published_at": "2021-11-17T08:00:00+00:00", "published_display": "17 Nov 2021 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 71, "total_relevant": 5, "sentiment_summary": {"positive": 1, "negative": 0, "neutral": 4, "score": 53, "total": 5, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 82, "events": [{"event": "general", "label": "Market update", "weight": 2.75, "count": 5}], "positive_events": 1, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 1.31, "latest_week": "2026-07-10", "one_week_move": 6.1, "four_week_move": -11.8, "twelve_week_move": -25.6, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.58026, "market_dynamics_buy_signal": false, "relative_strength": -39.718471, "fair_value_gap": -53.1, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 39.2915, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+6.1% over one week, -11.8% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 62, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Biostock", "count": 2}, {"label": "TradingView", "count": 1}, {"label": "The Armchair Trader", "count": 1}, {"label": "medwatch.com", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 5}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 5}]}, "insights": [{"label": "Weighted tone", "value": "53/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "82/100 classification confidence."}, {"label": "Company focus", "value": "5", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+6.1% over one week, -11.8% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "REPORT FROM PILA PHARMA AB\u2019S ANNUAL GENERAL MEETING 2026"}], "updated_at": "2026-07-18T07:05:23.500284+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}